Skip to Content

Impoyz Approval History

FDA Approved: Yes (First approved November 28, 2017)
Brand name: Impoyz
Generic name: clobetasol propionate
Dosage form: Cream
Company: Dr. Reddy's Laboratories, Inc.
Treatment for: Plaque Psoriasis

Impoyz (clobetasol propionate) is a high potency topical corticosteroid indicated for the treatment of moderate to severe plaque psoriasis.

Development History and FDA Approval Process for Impoyz

DateArticle
Dec  1, 2017Approval Dr. Reddy’s Announces Approval of Impoyz (clobetasol propionate) Cream for Plaque Psoriasis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide